• Von Willebrand Factor (VWF) is crucial to platelet adhesion and proper effective coagulation. It also appears to be associated with inflammation and sepsis. Join us for a thought-provoking webinar entitled Von Willebrand Factor: Friend or Foe? as we explore the many faces of VWF.
  • Experts Xinglong Zheng, MD, PhD, Professor and Chair of Pathology and Laboratory Medicine at the University of Kansas Medical Center and George A. Fritsma, MS, MLS, Proprietor of The Fritsma Factor, will explore the many aspects of VWF, including possible links to venous thrombosis, heart disease, and stroke and the well-documented relationship with ADAMTS13 in TTP.
Date: Tuesday, January 26, 2021
Time: 5 PM US EST (GMT: 22:00)
Duration: 60 minutes
Accreditation: BioMedica Diagnostics, Inc. is approved as
a provider of continuing education programs in the clinical laboratory
sciences by the ASCLS P.A.C.E.® Program.
Join this conversation on hemostasis and von Willebrand factor.
Invite your colleagues to join you for this informative dialogue with
Dr. Zheng and Mr. Fritsma by sharing the link: 
For Further Reading:
Zheng L, Zhang D, Cao W, Song W, Zheng X. Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy. Blood. 2019; doi: 10.1182/blood.2019001040.
This webinar has been supported by an educational grant from BioMedica Diagnostics, Inc.,
a member of the Scotia Investments family of companies.